The Effect and Safety of Low Dose Nebulized Epinephrine in Croup
Primary Purpose
Croup, Epinephrine, Administration, Inhalation
Status
Unknown status
Phase
Phase 4
Locations
Korea, Republic of
Study Type
Interventional
Intervention
conventional dose epinephrine
low dose epinephrine
Sponsored by

About this trial
This is an interventional treatment trial for Croup focused on measuring croup, dose, epinephrine
Eligibility Criteria
Inclusion Criteria:
- croup children between 6 month and 5 years old
- Westley croup score between 3 and 11
Exclusion Criteria:
- underlying lung or heart disase
- contra indication to dexamethasone
- immune deficient state
- preterm birth
- previous intubation or apnea history
Sites / Locations
- Seoul National University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
conventional dose epinephrine
low dose epinephrine
Arm Description
L-epinephrine (1:1000) 0.5 mL/kg (maximum 5mL) + normal saline : total 5mL
L-epinephrine (1:1000) 0.1 mL/kg (maximum 1mL) + normal saline : total 5mL
Outcomes
Primary Outcome Measures
the difference of Westley croup score between baseline and 30 minutes after neublized treatment
Secondary Outcome Measures
the incidence of use of additional neublized treatment
Westley croup score
the side effect of epinephrine
Hypertension, tachycardia : more than 95th percentile for age Arrythmia Pallor Tremor
respiratory rate, oxygen saturation
health care utilization- length of stay in emergency department, admission rate, revisit dut to croup symptom
treatment failure
after additional nebulized epineprhine at 30 minutes, as the croup scrore is higher than baselin, the blinding is cleared.
rebound effect
the croup score is the same or over than the base line
Full Information
NCT ID
NCT01664507
First Posted
August 3, 2012
Last Updated
January 6, 2018
Sponsor
Seoul National University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01664507
Brief Title
The Effect and Safety of Low Dose Nebulized Epinephrine in Croup
Official Title
The Effect and Safety of Low Dose Nebulized Epinephrine in the Treatment of Croup
Study Type
Interventional
2. Study Status
Record Verification Date
January 2018
Overall Recruitment Status
Unknown status
Study Start Date
January 2016 (undefined)
Primary Completion Date
August 2018 (Anticipated)
Study Completion Date
August 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seoul National University Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Croup is common illness presenting emergency department with dyspnea. The main treatment for croup is nebulized L-epinephrine and steroid. The study for the dose of nebulized L-epinephrine is restricted that the study of comparision between racemic epinephrine and L-epinephrine.
The investigators conducted this study to compare the effectiveness of low dose L-epinephrine with conventional dose L-epinephrine.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Croup, Epinephrine, Administration, Inhalation
Keywords
croup, dose, epinephrine
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
84 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
conventional dose epinephrine
Arm Type
Active Comparator
Arm Description
L-epinephrine (1:1000) 0.5 mL/kg (maximum 5mL) + normal saline : total 5mL
Arm Title
low dose epinephrine
Arm Type
Experimental
Arm Description
L-epinephrine (1:1000) 0.1 mL/kg (maximum 1mL) + normal saline : total 5mL
Intervention Type
Drug
Intervention Name(s)
conventional dose epinephrine
Intervention Description
conventional dose epinephrine : 0.5mg/kg + 0.9% normal saline
Intervention Type
Drug
Intervention Name(s)
low dose epinephrine
Intervention Description
low dose epineprhine : 0.1mg/kg + 0.9% normal saline
Primary Outcome Measure Information:
Title
the difference of Westley croup score between baseline and 30 minutes after neublized treatment
Time Frame
30 minutes
Secondary Outcome Measure Information:
Title
the incidence of use of additional neublized treatment
Time Frame
30 minutes
Title
Westley croup score
Time Frame
30, 60, 90, 120, 180, 240 minutes
Title
the side effect of epinephrine
Description
Hypertension, tachycardia : more than 95th percentile for age Arrythmia Pallor Tremor
Time Frame
participants will be followed for the duration of ED stay
Title
respiratory rate, oxygen saturation
Time Frame
30, 60, 90, 120, 180, 240 minutes
Title
health care utilization- length of stay in emergency department, admission rate, revisit dut to croup symptom
Time Frame
within 7 days
Title
treatment failure
Description
after additional nebulized epineprhine at 30 minutes, as the croup scrore is higher than baselin, the blinding is cleared.
Time Frame
30min after 2nd epinephrine nebulizer
Title
rebound effect
Description
the croup score is the same or over than the base line
Time Frame
180 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
croup children between 6 month and 5 years old
Westley croup score between 3 and 11
Exclusion Criteria:
underlying lung or heart disase
contra indication to dexamethasone
immune deficient state
preterm birth
previous intubation or apnea history
Facility Information:
Facility Name
Seoul National University Hospital
City
Seoul
ZIP/Postal Code
110-744
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jin Hee Lee, Professor
Phone
+82-2-2072-4910
Email
gienee74@gmail.com
First Name & Middle Initial & Last Name & Degree
Jin Hee Lee, Professor
First Name & Middle Initial & Last Name & Degree
Hyuksool kwon, Professor
12. IPD Sharing Statement
Citations:
PubMed Identifier
30878411
Citation
Lee JH, Jung JY, Lee HJ, Kim DK, Kwak YH, Chang I, Kwon H, Choi YJ, Park JW, Paek SH, Cho JH. Efficacy of low-dose nebulized epinephrine as treatment for croup: A randomized, placebo-controlled, double-blind trial. Am J Emerg Med. 2019 Dec;37(12):2171-2176. doi: 10.1016/j.ajem.2019.03.012. Epub 2019 Mar 8.
Results Reference
derived
Learn more about this trial
The Effect and Safety of Low Dose Nebulized Epinephrine in Croup
We'll reach out to this number within 24 hrs